Berberine inhibits hepatic gluconeogenesisviathe LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats

Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions

(2014) Sanna-Mari Aatsinki et al.   BRITISH JOURNAL OF PHARMACOLOGY

Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells

(2013) Shijie Cao et al.   JOURNAL OF ETHNOPHARMACOLOGY

Effects of Chinese Fructus Mume formula and its separated prescription extract on insulin resistance in type 2 diabetic rats

(2013) Jing-bin Li et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis

(2012) Ming Zhang et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

AICAR response element binding protein (AREBP), a key modulator of hepatic glucose production regulated by AMPK in vivo

(2011) Tomomi Shirai et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis

(2011) Xuan Xia et al.   PLoS One

Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein

(2009) Ling He et al.   CELL

Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression

(2008) Wei-Jia Kong et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK α2-subunit (PRKAA2) and risk of type 2 diabetes

(2007) Parvaneh Keshavarz et al.   MOLECULAR GENETICS AND METABOLISM